These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21789245)

  • 1. Energy metabolism in H460 lung cancer cells: effects of histone deacetylase inhibitors.
    Amoêdo ND; Rodrigues MF; Pezzuto P; Galina A; da Costa RM; de Almeida FC; El-Bacha T; Rumjanek FD
    PLoS One; 2011; 6(7):e22264. PubMed ID: 21789245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal modulation of histone deacetylase inhibitors sodium butyrate and trichostatin A on the energy metabolism of breast cancer cells.
    Rodrigues MF; Carvalho É; Pezzuto P; Rumjanek FD; Amoêdo ND
    J Cell Biochem; 2015 May; 116(5):797-808. PubMed ID: 25510910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages.
    Rahman MM; Kukita A; Kukita T; Shobuike T; Nakamura T; Kohashi O
    Blood; 2003 May; 101(9):3451-9. PubMed ID: 12511413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Casiopeina II-gly and bromo-pyruvate inhibition of tumor hexokinase, glycolysis, and oxidative phosphorylation.
    Marín-Hernández A; Gallardo-Pérez JC; López-Ramírez SY; García-García JD; Rodríguez-Zavala JS; Ruiz-Ramírez L; Gracia-Mora I; Zentella-Dehesa A; Sosa-Garrocho M; Macías-Silva M; Moreno-Sánchez R; Rodríguez-Enríquez S
    Arch Toxicol; 2012 May; 86(5):753-66. PubMed ID: 22349057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPK-mediated increase of glycolysis as an adaptive response to oxidative stress in human cells: implication of the cell survival in mitochondrial diseases.
    Wu SB; Wei YH
    Biochim Biophys Acta; 2012 Feb; 1822(2):233-47. PubMed ID: 22001850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.
    Shen YA; Wang CY; Hsieh YT; Chen YJ; Wei YH
    Cell Cycle; 2015; 14(1):86-98. PubMed ID: 25483072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the antitumoral alkylating agent 3-bromopyruvate on mitochondrial respiration: role of mitochondrially bound hexokinase.
    Rodrigues-Ferreira C; da Silva AP; Galina A
    J Bioenerg Biomembr; 2012 Feb; 44(1):39-49. PubMed ID: 22322891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
    Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE
    Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of culture conditions, culture media volumes, and glucose content on metabolic properties of renal epithelial cell cultures. Are renal cells in tissue culture hypoxic?
    Gstraunthaler G; Seppi T; Pfaller W
    Cell Physiol Biochem; 1999; 9(3):150-72. PubMed ID: 10494029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells.
    Wang ZT; Chen ZJ; Jiang GM; Wu YM; Liu T; Yi YM; Zeng J; Du J; Wang HS
    Cell Signal; 2016 May; 28(5):506-515. PubMed ID: 26876786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor.
    Trtková K; Pašková L; Matiješčuková N; Kolář Z
    Cancer Biomark; 2010; 7(2):79-90. PubMed ID: 21178266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of AR to SMRT/N-CoR complex and its co-operation with PSA promoter in prostate cancer cells treated with natural histone deacetylase inhibitor NaB.
    Trtkova K; Paskova L; Matijescukova N; Strnad M; Kolar Z
    Neoplasma; 2010; 57(5):406-14. PubMed ID: 20568894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.
    Suenaga M; Soda H; Oka M; Yamaguchi A; Nakatomi K; Shiozawa K; Kawabata S; Kasai T; Yamada Y; Kamihira S; Tei C; Kohno S
    Int J Cancer; 2002 Feb; 97(5):621-5. PubMed ID: 11807787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose of histone deacetylase inhibitors affects insulin secretory mechanism of pancreatic beta cell line.
    Yamato E
    Endocr Regul; 2018 Jan; 52(1):21-26. PubMed ID: 29453918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells.
    Zhang F; Zhang T; Teng ZH; Zhang R; Wang JB; Mei QB
    Cancer Biol Ther; 2009 May; 8(9):823-31. PubMed ID: 19270532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synergistic cytotoxicity effect of histone deacetylase inhibitor combined with paclitaxel on lung cancer cell lines and its mechanism].
    Zhang D; Liu CT; Yu XD; Liu Y
    Ai Zheng; 2009 Dec; 28(12):1270-6. PubMed ID: 19958621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells.
    Duncan HF; Smith AJ; Fleming GJ; Cooper PR
    J Endod; 2012 Mar; 38(3):339-45. PubMed ID: 22341071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors.
    Countryman JK; Gradoville L; Miller G
    J Virol; 2008 May; 82(10):4706-19. PubMed ID: 18337569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling cancer glycolysis under hypoglycemia, and the role played by the differential expression of glycolytic isoforms.
    Marín-Hernández A; López-Ramírez SY; Del Mazo-Monsalvo I; Gallardo-Pérez JC; Rodríguez-Enríquez S; Moreno-Sánchez R; Saavedra E
    FEBS J; 2014 Aug; 281(15):3325-45. PubMed ID: 24912776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.